Literature DB >> 26553440

Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).

Veria Khosrawipour1,2, Tanja Khosrawipour2, David Diaz-Carballo3, Eckart Förster4, Jürgen Zieren1,2, Urs Giger-Pabst5,6.   

Abstract

BACKGROUND: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel approach to delivering intraperitoneal chemotherapy (IPC) as a pressurized aerosol. One of the assumed advantages is the homogeneous drug distribution in the intraperitoneal cavity compared with conventional liquid in situ chemotherapy. However, to date, the spatial drug distribution pattern of PIPAC has not been investigated in detail.
METHODS: Doxorubicin was aerosolized in an ex vivo PIPAC model containing native fresh tissue samples of swine peritoneum at a pressure of 12 mmHg CO2 at 36 °C. In the center of the top cover of the PIPAC chamber, a PIPAC micropump was installed. Tissue specimens were placed as follows: (A) bottom of the plastic box, (B) margin of the aerosol jet covered with a bilaterally open tunnel, (C) side wall, and (D) top cover, respectively. In-tissue doxorubicin penetration was measured using fluorescence microscopy on frozen thin sections.
RESULTS: The depth of doxorubicin penetration was found to be significantly higher in tissues directly exposed to the aerosol jet (A: 215 ± 79 µm) compared with the side wall (C: 77 ± 18 µm; p < 0.01) and the top of the box (D: 65 ± 17 µm; p < 0.01). The poorest penetration was observed for peritoneal tissue covered under a bilaterally open plastic tunnel (B: 34 ± 19 µm; p < 0.001).
CONCLUSIONS: The study data suggest that the spatial drug distribution pattern of ex vivo PIPAC is heterogeneous.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26553440     DOI: 10.1245/s10434-015-4954-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  30 in total

1.  Assessment of the aerosol distribution pattern of a single-port device for intraperitoneal administration of therapeutic substances.

Authors:  Rafael Seitenfus; Antonio Nocchi Kalil; Eduardo Dipp de Barros; Claudio Galeano Zettler; Gabriel Oliveira Dos Santos; Olivier Glehen; Carlos Humberto Cereser Junior; Paulo Roberto Walter Ferreira
Journal:  Surg Endosc       Date:  2019-08-01       Impact factor: 4.584

2.  Technical description of the microinjection pump (MIP®) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC).

Authors:  Daniel Göhler; Veria Khosrawipour; Tanja Khosrawipour; David Diaz-Carballo; Thomas Albert Falkenstein; Jürgen Zieren; Michael Stintz; Urs Giger-Pabst
Journal:  Surg Endosc       Date:  2016-09-08       Impact factor: 4.584

3.  HIPEC Methodology and Regimens: The Need for an Expert Consensus.

Authors:  Aditi Bhatt; Ignace de Hingh; Kurt Van Der Speeten; Martin Hubner; Marcello Deraco; Naoual Bakrin; Laurent Villeneuve; Shigeki Kusamura; Olivier Glehen
Journal:  Ann Surg Oncol       Date:  2021-06-17       Impact factor: 5.344

Review 4.  The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review.

Authors:  Robin J Lurvink; Kurt Van der Speeten; Koen P Rovers; Ignace H J T de Hingh
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 5.  Pressurized intraperitoneal aerosol chemotherapy for recurrent ovarian, fallopian or primary peritoneal cancer with peritoneal carcinomatosis: a narrative review.

Authors:  Soohyun Oh; Haerin Paik; Soo Jin Park; Eun Ji Lee; Hee Seung Kim
Journal:  Gland Surg       Date:  2021-03

6.  Scintigraphic peritoneography reveals a non-uniform 99mTc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model.

Authors:  Alexander Bellendorf; Veria Khosrawipour; Tanja Khosrawipour; Simon Siebigteroth; Joseph Cohnen; David Diaz-Carballo; Andreas Bockisch; Jürgen Zieren; Urs Giger-Pabst
Journal:  Surg Endosc       Date:  2017-06-22       Impact factor: 4.584

7.  Feasibility and Characteristics of Pressurized Aerosol Chemotherapy (PAC) in the Bladder as a Therapeutical Option in Early-stage Urinary Bladder Cancer.

Authors:  Agata Mikolajczyk; Veria Khosrawipour; Justyna Schubert; Michal Plociennik; Kacper Nowak; Christian Fahr; Haris Chaudhry; Tanja Khosrawipour
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

Review 8.  [PIPAC and HIPEC-competing or supplementary therapeutic procedures for peritoneal metastases].

Authors:  H Leebmann; P Piso
Journal:  Chirurg       Date:  2018-09       Impact factor: 0.955

9.  A new ex vivo model for optimizing distribution of therapeutic aerosols: the (inverted) bovine urinary bladder.

Authors:  Daniel Schnelle; Frank-Jürgen Weinreich; Janek Kibat; Marc A Reymond
Journal:  Pleura Peritoneum       Date:  2017-03-11

10.  Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum.

Authors:  Soo Jin Park; Eun Ji Lee; Hee Su Lee; Junsik Kim; Sunwoo Park; Jiyeon Ham; Jaehee Mun; Haerin Paik; Hyunji Lim; Aeran Seol; Ga Won Yim; Seung-Hyuk Shim; Beong-Cheol Kang; Suk Joon Chang; Whasun Lim; Gwonhwa Song; Jae-Weon Kim; Nara Lee; Ji Won Park; Jung Chan Lee; Hee Seung Kim
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.